LipidDrive - Lipidomics cloud computing platform and app

Akronyymi

LipidDrive

Rahoitetun hankkeen kuvaus

LipidDrive is a breakthrough cloud computing platform and mobile app that allows researchers in the growing field of lipidomics to process, store and share analytical data in a standardized format. Lipidomics is the study of lipid molecules in cells, tissues and biofluids. Due to its low cost, high accuracy and deep insights into cellular function, it has the potential to revolutionize medical science. However it is blocked by a lack of data standardization, processing capacity and collaboration. There are no common protocols for lipidomics data output. 70% of lipidomics data is incomparible, wasting €14 million in research costs annually. Tests require large computer processing power, which most researchers do not possess. There are few online resources for data collaboration. Addressing these challenges, LipidDrive is a cloud-based platform for high-quality lipidomics data analysis. Users upload mass spectrometry data sets, which are processed by algorithms to ensure quality control, and are output according to new data standards. LipidDrive’s cloud computing service processes high-throughput data in any format, replacing desktop-based software with limited capacity. It also provides an online resource of latest research, lipid and biomarker libraries, communication tools and APIs for third-party data utilization. LipidDrive is an unrivaled ICT service developed by Dr Kim Ekroos, a leading lipidomics expert. It will target researchers in universities, pharmaceutical and nutritional industries, and hospitals and clinics through direct sales and partnerships with hardware vendors. Demand and willingness to pay have been confirmed by interest from several large pharmaceutical companies. Lipidomics is expected to follow the growth path of proteomics, which is worth €20 billion annually. LipidDrive will become the most valuable online resource for this fast-emerging industry. The proposed feasibility study will test the technology and prepare for commercialization.
Näytä enemmän

Aloitusvuosi

2017

Päättymisvuosi

2018

Myönnetty rahoitus

LIPIDOMICS CONSULTING OY AB - LIPIDOMICS CONSULTING LTD
Coordinator

Myönnetty summa

50 000 €

Rahoittaja

Euroopan unioni

Rahoitusmuoto

SME instrument phase 1

Puiteohjelma

Horizon 2020 Framework Programme

Haku

Ohjelman osa
INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT) (5239)
Mainstreaming SME support, especially through a dedicated instrument (5284)
Health (5290)
Active ageing and self-management of health (5302)
Health care provision and integrated care (5309)
Aihe
Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well (SMEInst-06-2016-2017)
Haun tunniste
H2020-SMEINST-1-2016-2017

Muut tiedot

Rahoituspäätöksen numero

781726

Tunnistetut aiheet

health care